Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma and Cerebrospinal Fluid (CSF) Pharmacokinetics of Bendamustine as a Component of Salvage Therapy for Primary Central Nervous System Lymphoma (PCNSL)

NCT03392714 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.

NCT NCT03392714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma and Cerebrospinal Fluid (CSF) Pharmacokinetics of Bendamustine as a Component of Salvage Therapy for Primary Central Nervous System Lymphoma (PCNSL)
Lead sponsor
Chonnam National University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 20, 2016
Completion date
January 20, 2019
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcnsl